Marijuana was thought of as has bad effects — impacting memory and thinking ability. Now the latest research points out that it in fact help with the effects of brain ageing. As per U.S. researchers very low levels of the compound THC, the active ingredient in the drug, may decelerate or stop the progression of Alzheimer’s disease. At the low doses analyzed, the therapeutic benefits of THC looked to override the connected risks of THC toxicity and memory impairment, they discovered. The research could help develop drugs to treat the disease from related compounds that are safe and legal.
1
Professor Chuanhai Cao, lead author of the study and a neuroscientist at the Byrd Alzheimer’s Institute in Florida, illustrated that THC lowers the quantity of amyloid beta in the brain. Amyloid beta triggers Alzheimer’s and researchers are presently trying to develop drugs that could help halt the production of this protein. Professor Cao said: ‘THC is known to be a potent antioxidant with neuroprotective properties. This is at the moment the single report that affirm THC lowers levels of the amyloid beta protein, defending against the progression of Alzheimer’s. 

Dr Neel Nabar, who co-authored the study said: ‘We haven’t yet reached a consensus, however, this study points out that THC and THC-related compounds may be of therapeutic value in Alzheimer’s disease,’ He continued: ‘Are we supporting that people start having illicit drugs to stop the disease? No. A week ago results of another study brought to light marijuana could be useful for medical purposes.

2
COULD POMEGRANATES BE A  REMEDY FOR ALZHEIMER’S?

An ingredient detected in pomegranates is said to decelerate the onset of Alzheimer’s and check some of its symptoms, a study has discovered. University of Huddersfield researchers discovered that punicalagin – a chemical compound present in the pomegranate fruit – presumably impede inflammation in specialised brain cells dubbed micrologia. (It is inflammation that prompt Alzheimer’s disease getting increasingly worse.) Dr Olumayokun Olajide, the lead author of the study, is trying to deduce how much pomegranate is required to be effective, but asserts daily consumption of the fruit is still beneficial.